Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension | Zendy

Kaycee M. Sink | Zendy; Xiaoyan Leng | Zendy; Jeff D. Williamson | Zendy; Stephen B. Kritchevsky | Zendy; Kristine Yaffe | Zendy; Lewis H. Kuller | Zendy; Sevil Yaşar | Zendy; Hal H. Atkinson | Zendy; Mike E. Robbins | Zendy; Bruce M. Psaty | Zendy; David C. Goff | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension

Author(s) -

Kaycee M. Sink,

Xiaoyan Leng,

Jeff D. Williamson,

Stephen B. Kritchevsky,

Kristine Yaffe,

Lewis H. Kuller,

Sevil Yaşar,

Hal H. Atkinson,

Mike E. Robbins,

Bruce M. Psaty,

David C. Goff

Publication year - 2009

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2009.175

Subject(s) - dementia , medicine , hazard ratio , odds ratio , angiotensin converting enzyme , confidence interval , cognitive decline , risk factor , heart failure , blood pressure , disease

Hypertension (HTN) is a risk factor for dementia, and animal studies suggest that centrally active angiotensin-converting enzyme (ACE) inhibitors (those that cross the blood-brain barrier) may protect against dementia beyond HTN control.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research